Autism News and Research

Latest Autism News and Research

Rethink Autism, eSchool News offer webinar to show how schools can save costs using new technology

Public school administrators are facing the prospect of deeper budget cuts in cities and states nationwide. Meanwhile, schools with fewer resources are challenged to comply with the federal Individuals with Disabilities Education Act, which guarantees "free appropriate" education to all disabled students, including the growing number of students with an Autism Spectrum Disorder. In addition, parents are pressuring schools to either comply with the IDEA or face legal action.

2 Aug 2010

Intra-Cellular Therapies ITI-007 Phase Ib/II clinical trial for schizophrenia meets primary endpoint

Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia.

30 Jul 2010

Saint Peter's University joins Curemark's clinical trial program for CM-AT autism treatment

Curemark, LLC , a drug research and development company focused on the treatment of neurological diseases, announced that Saint Peter's University Hospital in New Brunswick, New Jersey, is participating in the company's Phase III clinical trials for CM-AT, Curemark's autism treatment.

29 Jul 2010

Texas raises organ donor registry; D.C. not ready for medical marijuana sales; L.A. health department facing major service cuts

"Though Texas has the nation's lowest percentage of registered organ and tissue donors, several recent initiatives have more than doubled the state's donor rolls this year. The number enrolled in the Glenda Dawson Donate Life Texas Registry has ballooned since Jan. 1, when state law required Department of Public Safety clerks to ask all driver's license and ID card applicants whether they would like to register as organ donors. Since then, nearly 70,000 donors a month have joined the pool" (George, 7/27).

29 Jul 2010

Genetic signals determine neurotransmitter use for communication

Cascades of genetic signals determine which neurotransmitter a brain cell will ultimately use to communicate with other cells. Now a pair of reports from biologists at the University of California, San Diego, have shown for the first time that electrical activity in these developing neurons can alter their chemical fate-and change an animal's behavior-by tweaking this genetic program.

29 Jul 2010

Quest Diagnostics' Fragile X Syndrome test receives New York State health department approval

An accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited mental retardation and the most common known single gene cause of autism.

From Quest Diagnostics 29 Jul 2010

NIH grants $14.85 million to complete two floors of NRI at Texas Children's Hospital

Neurological research at Baylor College of Medicine and Texas Children's Hospital is getting a big boost in the form of a $14.85 million grant from the National Institutes of Health to complete two floors of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital.

29 Jul 2010

First Edition: July 28, 2010

Today's headlines reflect developments regarding the health insurance marketplace and the implementation of the new health law.

28 Jul 2010

New study on treating CP with HBOT is making waves in India, U.S.

A new study on treating Cerebral Palsy with Hyperbaric Oxygen Therapy is making waves in India and the U.S. The largest sample of children studied to assess neuro-developmental improvements focuses on a combination of standard rehabilitation therapies, such as Occupational, Physical, Speech Therapies and HBOT.

28 Jul 2010

Need for better understanding of appropriate treatment choices for children with insomnia: Study

A new survey of child psychiatrists indicates that insomnia is a major problem among children in mental health treatment and at least a quarter of these patients are given sleep medication. The results of the survey, conducted by Judith Owens, MD, a sleep expert with Hasbro Children's Hospital, and colleagues, suggests that management of insomnia in this population is a common practice, although the clinical approach varies widely. The study is published in the August 2010 edition of Sleep Medicine.

27 Jul 2010

Parents of children with ASD turn to evidence-based behavioral treatment methods

One of the most common initial red flags reported by parents of children with autism is that they suspect their child may be deaf because he or she no longer responds to his or her name, and does not look at them when they speak. However, the lack of response or eye contact can point to an Autism Spectrum Disorder. In fact, many children on the autism spectrum do not demonstrate typical language skills and social behavior, or even lose language or social skills they once had.

27 Jul 2010

Seaside Therapeutics reports positive data from STX209 Phase 2 study in fragile X syndrome

Seaside Therapeutics, Inc. announced today data from the largest randomized, placebo-controlled study conducted to date in individuals with fragile X syndrome. In a Phase 2 study of STX209, clinically meaningful improvements on global and specific neurobehavioral outcomes were observed in the general study population. The improvements were statistically significant in pediatric patients with more severe impairments in sociability -- a core symptom of fragile X syndrome.

26 Jul 2010

Asuragen reports collaborative study results of advanced PCR-based molecular profiling of FMR1 gene

Asuragen, Inc. announced today the results from two collaborative studies, one with the University of California Davis M.I.N.D. Institute and another with Rush University Medical Center, that demonstrate comprehensive molecular profiling of the Fragile X Mental Retardation (FMR1) gene using advanced PCR-based methods.

26 Jul 2010

Preclinical data of new acamprosate prodrug to be presented at International Fragile X Conference

XenoPort, Inc. announced today that it has discovered a novel prodrug that has the potential to improve significantly the blood concentration of acamprosate compared with the currently approved formulation of acamprosate. Preclinical data on this new product candidate will be presented tomorrow at the National Fragile X Foundation's 12th International Fragile X Conference in Detroit, Michigan.

23 Jul 2010

Research on new treatments for FXS to be presented at International Fragile X Conference

Accelerated research findings leading to potentially significant new treatments for fragile X syndrome will be presented to nearly 1,000 family members and professionals at the 12th International Fragile X Conference in Dearborn July 21-25.

23 Jul 2010

Call for greater support in mental health services for children

As support for funds for mental ailments mounts, a coalition of mental health experts are lobbying for greater support for mental health services for children. The coalition comprises The Royal Australian and New Zealand College of Psychiatrists; the Australian Psychological Society; NIFTeY (National Investment for the Early Years); the Australian Infant, Child, Adolescent and Family Mental Health Association; the Australian Association of Infant Mental Health, and the Australian Child and Adolescent Trauma, Loss and Grief Network.

22 Jul 2010

New research identifies stem cells that generate three critical classes of nerve cells

New research, published in the journal Development, by Dr. Anthony-Samuel LaMantia, professor of Pharmacology & Physiology and director of the newly formed GW Institute for Neuroscience, and his colleagues have identified the stem cells that generate three critical classes of nerve cells - olfactory receptors, vomeronasal and gonadotropin releasing hormone neurons - that are responsible for enabling animals and humans, to eat, interact socially and reproduce.

22 Jul 2010

Survey links autism with digestive problems, intestinal inflammation

Autism is the fastest growing developmental disorder in the world. With 1 child in 91 facing the disorder, the diagnosis is more common than pediatric cancer, diabetes, and AIDS combined.

22 Jul 2010

Washington University's new Intellectual and Developmental Disabilities Research Center to focus on children

Improving the lives of infants and children with developmental disabilities will be the focus of Washington University's new Intellectual and Developmental Disabilities Research Center (WUIDDRC).

21 Jul 2010

Eurotech enters multiple contracts with DynaVox for Catalyst embedded computers

Eurotech, a leading supplier of embedded technologies, products, and systems, today announces multiple contracts with DynaVox to deliver the Catalyst LP and Catalyst Module embedded computers for the DynaVox V, Vmax and Xpress™ alternative augmentative communication (AAC) devices. The combined value of these contracts is nearly 4.2M USD, with deliveries to be made in 2010 and 2011.

20 Jul 2010

Autism News and Research

Latest Autism News and Research

Rethink Autism, eSchool News offer webinar to show how schools can save costs using new technology

Intra-Cellular Therapies ITI-007 Phase Ib/II clinical trial for schizophrenia meets primary endpoint

Saint Peter's University joins Curemark's clinical trial program for CM-AT autism treatment

Texas raises organ donor registry; D.C. not ready for medical marijuana sales; L.A. health department facing major service cuts

Genetic signals determine neurotransmitter use for communication

Quest Diagnostics' Fragile X Syndrome test receives New York State health department approval

NIH grants $14.85 million to complete two floors of NRI at Texas Children's Hospital

First Edition: July 28, 2010

New study on treating CP with HBOT is making waves in India, U.S.

Need for better understanding of appropriate treatment choices for children with insomnia: Study

Parents of children with ASD turn to evidence-based behavioral treatment methods

Seaside Therapeutics reports positive data from STX209 Phase 2 study in fragile X syndrome

Asuragen reports collaborative study results of advanced PCR-based molecular profiling of FMR1 gene

Preclinical data of new acamprosate prodrug to be presented at International Fragile X Conference

Research on new treatments for FXS to be presented at International Fragile X Conference

Call for greater support in mental health services for children

New research identifies stem cells that generate three critical classes of nerve cells

Survey links autism with digestive problems, intestinal inflammation

Washington University's new Intellectual and Developmental Disabilities Research Center to focus on children

Eurotech enters multiple contracts with DynaVox for Catalyst embedded computers

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Autism News and Research

Latest Autism News and Research

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Newsletters you may be interested in